DE122005000046I1 - Azellul{rer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enth{lt. - Google Patents

Azellul{rer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enth{lt.

Info

Publication number
DE122005000046I1
DE122005000046I1 DE200512000046 DE122005000046C DE122005000046I1 DE 122005000046 I1 DE122005000046 I1 DE 122005000046I1 DE 200512000046 DE200512000046 DE 200512000046 DE 122005000046 C DE122005000046 C DE 122005000046C DE 122005000046 I1 DE122005000046 I1 DE 122005000046I1
Authority
DE
Germany
Prior art keywords
diphtheria
tetanus toxoid
vaccine containing
pertussis vaccine
acellular pertussis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE200512000046
Other languages
English (en)
Inventor
Patrick Florent
Jean Stephenne
Christiansa. Vandecasserie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of DE122005000046I1 publication Critical patent/DE122005000046I1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE200512000046 1996-11-07 2005-06-16 Azellul{rer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enth{lt. Pending DE122005000046I1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9623233.5A GB9623233D0 (en) 1996-11-07 1996-11-07 Vaccine composition

Publications (1)

Publication Number Publication Date
DE122005000046I1 true DE122005000046I1 (de) 2005-12-29

Family

ID=10802615

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69715031T Expired - Lifetime DE69715031T2 (de) 1996-11-07 1997-11-04 Azellulärer pertussis-impfstoff, der ein diphtherie-toxoid und ein tetanus-toxoid enthält
DE69733285T Expired - Lifetime DE69733285T3 (de) 1996-11-07 1997-11-04 Azellulärer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxid ent- hält
DE200512000046 Pending DE122005000046I1 (de) 1996-11-07 2005-06-16 Azellul{rer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enth{lt.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69715031T Expired - Lifetime DE69715031T2 (de) 1996-11-07 1997-11-04 Azellulärer pertussis-impfstoff, der ein diphtherie-toxoid und ein tetanus-toxoid enthält
DE69733285T Expired - Lifetime DE69733285T3 (de) 1996-11-07 1997-11-04 Azellulärer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxid ent- hält

Country Status (30)

Country Link
EP (2) EP1240905B3 (de)
JP (1) JP3980652B2 (de)
KR (1) KR100518044B1 (de)
CN (1) CN1130226C (de)
AR (1) AR011509A1 (de)
AT (2) ATE295178T1 (de)
AU (1) AU710475B2 (de)
BR (2) BR9712917A (de)
CA (1) CA2271008C (de)
CO (1) CO4910171A1 (de)
CY (2) CY2407B1 (de)
CZ (1) CZ295954B6 (de)
DE (3) DE69715031T2 (de)
DK (2) DK1240905T5 (de)
ES (2) ES2182131T3 (de)
GB (1) GB9623233D0 (de)
HK (2) HK1050473B (de)
HU (1) HU224126B1 (de)
IL (1) IL129530A (de)
LU (1) LU91183I2 (de)
NO (2) NO320186B1 (de)
NZ (1) NZ335384A (de)
PL (1) PL188460B1 (de)
PT (2) PT941117E (de)
SA (1) SA98181128B1 (de)
SI (2) SI1240905T1 (de)
TR (1) TR199900979T2 (de)
TW (1) TW471971B (de)
WO (1) WO1998019702A1 (de)
ZA (1) ZA979984B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004314A1 (de) * 1998-11-26 2000-05-31 Pasteur Merieux MSD T.d.Polio Impstoff für einer primovakzinierter oder empfindlicher Population
KR100374813B1 (ko) * 2000-04-07 2003-03-03 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP5007425B2 (ja) * 2006-01-30 2012-08-22 財団法人ヒューマンサイエンス振興財団 百日咳ワクチンの安全性評価方法
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
BR112012004806B8 (pt) 2009-09-02 2022-10-04 Novartis Ag composições imunogênicas que incluem moduladores da atividade de tlr, método para aumento da eficácia da referida composição e uso
AU2011295853A1 (en) 2010-09-01 2013-04-04 Irm Llc Adsorption of immunopotentiators to insoluble metal salts
JP6191082B2 (ja) 2011-03-02 2017-09-06 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム より低用量の抗原および／またはアジュバントを有する混合ワクチン
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
CA2866406A1 (en) 2012-03-08 2013-09-12 Novartis Ag Adjuvanted formulations of booster vaccines
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
JP2015525794A (ja) 2012-08-06 2015-09-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
MX362793B (es) 2013-03-08 2019-02-13 Janssen Vaccines & Prevention Bv Vacuna acelular contra pertussis.
BE1022008B1 (fr) 2013-08-05 2016-02-03 Glaxosmithkline Biologicals S.A. Compositions immunogenes combinees
CN114748616A (zh) * 2022-05-23 2022-07-15 中国医学科学院医学生物学研究所 一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) * 2023-01-10 2024-04-19 康希诺生物股份公司 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861417A0 (fi) 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
AP56A (en) 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.
EP0304578B1 (de) 1987-06-22 2001-10-24 Medeva Holdings Bv Hepatitis-B-Oberflächenantigen enthaltendes Peptid
EP0299108B1 (de) 1987-07-17 1994-05-18 Rhein Biotech Gesellschaft für biotechnologische Prozesse und Produkte mbH DNA-Moleküle, die für FMDH-Kontrollabschnitte und Strukturgene für ein Protein mit FMDH-Aktivität kodieren, sowie deren Anwendung
DE69031556T2 (de) 1989-07-25 1998-05-14 Smithkline Beecham Biolog Antigene sowie Verfahren zu deren Herstellung
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
DE69319728T2 (de) 1992-05-23 1999-02-04 Smithkline Beecham Biolog Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten

Also Published As

Publication number Publication date
JP3980652B2 (ja) 2007-09-26
HK1022638A1 (en) 2000-08-18
LU91183I2 (fr) 2005-09-20
NO992156L (no) 1999-05-04
ATE295178T1 (de) 2005-05-15
CY2407B1 (en) 2004-09-10
IL129530A0 (en) 2000-02-29
DE69715031T2 (de) 2003-05-08
BRPI9712917B1 (pt) 2019-12-03
EP0941117B1 (de) 2002-08-28
SI0941117T1 (en) 2002-12-31
CZ164099A3 (cs) 1999-10-13
DE69733285T3 (de) 2010-03-25
WO1998019702A1 (en) 1998-05-14
NZ335384A (en) 2000-10-27
CN1236321A (zh) 1999-11-24
DK1240905T5 (da) 2010-01-11
DE69733285T2 (de) 2006-01-12
ZA979984B (en) 1998-07-23
SI1240905T1 (en) 2005-10-31
CY2568B1 (en) 2008-07-02
EP1240905B1 (de) 2005-05-11
IL129530A (en) 2005-11-20
KR100518044B1 (ko) 2005-09-30
ES2182131T3 (es) 2003-03-01
CO4910171A1 (es) 2000-04-24
EP1240905A1 (de) 2002-09-18
DK1240905T3 (da) 2005-07-18
GB9623233D0 (en) 1997-01-08
JP2001503422A (ja) 2001-03-13
TR199900979T2 (xx) 1999-07-21
PT1240905E (pt) 2005-09-30
HUP9904287A3 (en) 2001-05-28
BRPI9712917B8 (pt) 2021-05-25
DE69715031D1 (de) 2002-10-02
HK1050473B (zh) 2006-03-03
DK0941117T3 (da) 2002-11-18
CZ295954B6 (cs) 2005-12-14
ES2240647T7 (es) 2010-03-31
PL333127A1 (en) 1999-11-22
SA98181128B1 (ar) 2006-03-25
KR20000053092A (ko) 2000-08-25
PL188460B1 (pl) 2005-02-28
NO992156D0 (no) 1999-05-04
AR011509A1 (es) 2000-08-30
CN1130226C (zh) 2003-12-10
NO2006005I2 (no) 2010-04-12
CA2271008A1 (en) 1998-05-14
NO2006005I1 (no) 2006-05-08
ATE222773T1 (de) 2002-09-15
CA2271008C (en) 2008-07-22
HUP9904287A1 (hu) 2000-04-28
AU5319698A (en) 1998-05-29
DE69733285D1 (de) 2005-06-16
EP0941117A1 (de) 1999-09-15
NO320186B1 (no) 2005-11-07
HK1050473A1 (en) 2003-06-27
ES2240647T3 (es) 2005-10-16
HU224126B1 (hu) 2005-05-30
BR9712917A (pt) 1999-12-07
PT941117E (pt) 2002-12-31
EP1240905B3 (de) 2009-08-26
TW471971B (en) 2002-01-11
AU710475B2 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
DE122005000046I1 (de) Azellul{rer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enth{lt.
NO20000202L (no) Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid
ATE121947T1 (de) Verbessertes meningokokkale polysaccharidkonjugatvakzin.
IL137809A0 (en) Pneumococcal and meningococcal vaccines formulated with interleukin-12
GB2234436A (en) Fish vaccine comprising a virulent,invasive bacterium
DE69110997T2 (de) Haemophilus Paragallinarum-Impfstoffe.
AU2001269569A1 (en) Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis surface antigen, and preparation method thereof
GB9611673D0 (en) Meningococcal vaccine
NO892997L (no) Bordetella pertussis vaksine.
AU4450696A (en) Enhanced immunogenic vaccine
ITMI912341A0 (it) Dispositivo di estrazione, in particolare estrattore a cingoli.
DE68918189D1 (de) Neisseria-Vakzine.
DE68917972T2 (de) Pertussistoxoid-Impfstoff.
GB9603322D0 (en) Viral preparations,immunogens and vaccines
IL144200A0 (en) A polynucleotide tuberculosis vaccine